Anti-Covid Therapies – New Research and Mechanisms of Action

Last year, our lives have turned upside down with the emergence of COVID-19 and the global pandemic that subsequently ensued. Globally there have now been over 165 million cases and over 3.5 million people have died. Despite the incidence of new covid infections falling dramatically, there is an urgent need for antiviral treatments to become available and urgent research is needed on novel and old molecules with antiviral properties.

This show is all about the new therapies being researched and developed in the fight against covid-19. One of the avenues of research is N-chlorotaurinen and anti-viral drugs.

Join Prof. Markus Nagl, Associate Professor, and Prof. Günter Weiss, Professor of Medicine and Biochemistry, both based at the Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Austria, to find out the difference between antiseptics (such as N-chlorotaurine) and antibiotics, its mechanisms of action and benefits from N-chlorotaurine for the patients. Our last guest of this show, Prof. Leif Bjermer, Professor of Allergy and Asthma Research at the University of Lund, Sweden, explains the added value of anti-viral drugs and what patients would benefit from antiviral drugs.